Revista Peruana de Reumatología : Volumen 2 Nº 1, Año 1996 LIMA-PERU

Bibliografía:

1. Cassidy J. JRA. In Textbook of Rheumatology. Kelley W (ed). Third edition, 1989.

2. Criteria for the diagnosis of Juvenile Rheumatoid Arthritis. Primer on Rheumatic Disease. Ninth edition. Edited by R Schumacher. The Arthritis Foundation. Atlanta GA, 1988; pp 318.

3. Jacob J. Juvenile Rheumatoid arthritis. in Jacobs J (ed): Pediatric Rheurnatology. New York, Springer-Verlag, 1982.

4. Lipnick RN, Tsokos GC, Magilavy DB. Inmune abnormalities in the pathogenesis of juvenile rheumatoid arthritis. Rheum Dis Clin North Am. 1991; 17: 843.

5. Tucker LB. Juvenile Rheumatoid Arthritis. Curr Opin Rheumatol 1993; 5: 619.

6. Javis JN, Kaplan J, Fine N. Increase in CD5 + B cells in juvenile rheumatoid arthritis. Arthritis Rheum 1992; 35: 204.

7. Martini A, Massa M, De Benedetti F, et al. CD5 positive B lymphocytes in seronegative juvenile arthritis. J Rheumatol 1990; 17: 932.

8. Mc Cune WJ, Wise PT, Cassidy JT. A comparison of antibody tests in children with juvenile rheumatoid arthritis on HEp-2 cell and mouse liver substrates. J Rheumatol 1986; 13: 980.

9. Southwood TR, Malleson PN. Antinuclear antibodies and juvenile chronic arthitis (JCA): Search for a specific autoantibody associated with JCA. Ann Rheum. Dis 1991; 50: 595.

10. Leak AM, Tuaillon N, Muller S, et al. Study of antibodies to histones and histone synthetic peptides in pauciarticular juvenile arthritis. Br J Rheumatol 1993; 32: 426.

11. Szer IS, Sierakowska H, Szer W. A new autoantibody to the putative oncogene dek is highly specific for pauciarticular juvenile rheumatoid arthritis (paujra). Arthritis Rheum 1993; 36: S55.

12. Moore TL, Dorne RW. Rheumatoid factors. Clin Biochem 1993; 26: 75.

13. Jarvis JN, Pousak T, Krenz M, et al. Complement activation and inmune complexes in juvenile rheumatoid artritis. J Rheumatol 1993; 20: 114.

14. Miller JJ, Hsu Y-P, Moss R, et al. The inmunology and clinical associations of the split products of C3 in plasma in juvenile rheumatoid arthritis. Arthritis Rheum 1979; 22: 502.

15. Ilowite NT, Wedgwood JR, Bonagura VR. Expression of the major cross-reactive idiotype of juvenile rheumatoid arthritis. Arthritis Rheum 1989; 32: 265.

16. Lawrence JM III, More TL, Osborn TG, et al. Autoantibody studies in juvenile rheumatoid arthritis. Semin Arthritis Rheum 1993; 22: 265.

17. Burgio GR, Martini A. Interleukin production in juvenile chronic arthritis. Ann Rheum Dis 1985; 44: 723.

18. Martini A, Ravell A, Notarangelo LD, et al. Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis. J Rheumatol 1986; 13: 598.

19. Prieur AM, Kaufman MT, Grisscelli C, et al. Interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 1987; 2: 1240.

20. Montezuma R. Arthritis Reumatoide Juvenil (Tesis Bachiller) Lima - Perú: Universidad Peruana Cayetano Heredia, 1967.

21. Llerena Y. Artritis Crónica Juvenil (Tesis Bachiller) Lima, Perú: Universidad Peruana Cayetano Heredia, 1985.

22. Ansell B. Juvenile Chronic Polyarthritis. Arthritis Rheum 1977; 20: S176.

23. Fink Ch. Patients with JRA, a clinical study. Arthritis Rheum 1977; 20: S183.

24. Calabro J. Artritis Reumatoide Juvenil. En Mc Carty (ed): Artritis y otras patologías relacionadas. 10.ª edición, 1987.

25. Hanson V, Kornreich H. Prognosis of JRA. Arthritis Rheum 1977; 20: S279.

26. Stillman S. Barry P. Juvenile Rheumatoid Arthritis. Arthritis Rheum 1977: 20: S171.

27. Miller JJ, Henrich V. Brandstrup N. Sex difference in incidence of antinuclear factors in juvenile rheumatoid arthritis. Pediatrics 1966; 38: 916.

28. Liza R. Manifestaciones oftalmológicas de la Artritis crónica juvenil (Tesis Bachiller) Lima, Perú: Universidad Peruana Cayetano Heredia, 1986.

29. Klippel J, Strober S, Wofay D. New therapies for the rheumatic disease. Bull Rheum Dis 1989; 38: 1.

30. Athreya B, Cassidy J. Current status of the medical treatment of children with JRA. Rheum Dis Clin North Am. 1991; 17: 871.

31. Levinson J. Reflections of a pediatric rheumatologist. Rheum Dis Clin North Am. 1987; 13: 149.

32. Schaaaller J. Corticosteroids in JRA. Arthritis Rheum 1977; 20: S537.

33. Truckenbordt H. Hafner R. Methotrexate therapy in JRA. Arthritis Rheum 1986; 29: 801.

34. Giannini E, Brewer E. For the Pediatric Rheumatology Collaborative study Group; Methotrexate in the treatment of recalcitrant JRA. Arthritis Reum 1989; 33: S582.

35. Wallace C, Bleyer W, Sherry D, Salmonson K. Toxicity and serum levels of methotrexate in children with JRA. Arthritis Rheum 1989; 32: 677.

36. Rose C, Singsen B, Eichenfield A. Goldsmith D. Safety and efficacy of methotrexate therapy of JRA. J Pediatr 1990; 77: 653.

Regresar al Artículo